These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9119122

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Biologicals: an attempt at classification and its implication for the viral safety of products.
    Horaud F.
    Dev Biol Stand; 1993; 81():17-24. PubMed ID: 8174800
    [No Abstract] [Full Text] [Related]

  • 23. Safety of biological products prepared from mammalian cell culture. Karyology.
    Dev Biol Stand; 1998; 93():134-6. PubMed ID: 9737392
    [No Abstract] [Full Text] [Related]

  • 24. Adventitious agents from animal-derived raw materials--a method of risk assessment.
    Foster LG.
    Dev Biol Stand; 1996; 88():283-90. PubMed ID: 9119152
    [Abstract] [Full Text] [Related]

  • 25. Validation of retroviral detection for rodent cell-derived products and gene therapy applications.
    Hughes JV, Messner K, Burnham M, Patel D, White EM.
    Dev Biol Stand; 1996; 88():297-304. PubMed ID: 9119153
    [Abstract] [Full Text] [Related]

  • 26. Safety of biological products prepared from mammalian cell culture. DNA.
    Dev Biol Stand; 1998; 93():136-8. PubMed ID: 9737393
    [No Abstract] [Full Text] [Related]

  • 27. Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization--a case study.
    Chen D, Nims R, Dusing S, Miller P, Luo W, Quertinmont M, Parekh B, Poorbaugh J, Boose JA, Atkinson EM.
    Biologicals; 2008 Nov; 36(6):393-402. PubMed ID: 18757212
    [Abstract] [Full Text] [Related]

  • 28. Issues related to harmonization of testing requirements for viral safety.
    Hayakawa T.
    Dev Biol Stand; 1996 Nov; 88():15-8. PubMed ID: 9119129
    [Abstract] [Full Text] [Related]

  • 29. Theoretical considerations on viral inactivation or elimination.
    Willkommen H, Löwer J.
    Dev Biol Stand; 1993 Nov; 81():109-16. PubMed ID: 8174793
    [No Abstract] [Full Text] [Related]

  • 30. Real-time quantitative PCR for retrovirus-like particle quantification in CHO cell culture.
    de Wit C, Fautz C, Xu Y.
    Biologicals; 2000 Sep; 28(3):137-48. PubMed ID: 10964440
    [Abstract] [Full Text] [Related]

  • 31. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
    Farshid M, Taffs RE, Scott D, Asher DM, Brorson K.
    Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Safety of biological products prepared from mammalian cell culture. Bovine spongiform encephalopathy and other non-viral transmissible agents.
    Dev Biol Stand; 1998 Oct; 93():133-4. PubMed ID: 9737391
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products. Proceedings of a meeting. Bethesda, Maryland, USA, June 14-16, 1995.
    Dev Biol Stand; 1996 Oct; 88():1-342. PubMed ID: 9119120
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.